Clinical trial
Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S.
NCT00328380 · Bausch Health Americas, Inc., Industry · Completed
Key facts
| NCT number | NCT00328380 |
|---|---|
| Title | Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S. |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety of Rifaximin for the Prevention of Travelers' Diarrhea in Subjects Traveling Outside the United States |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diarrhea |
| Intervention type | Drug |
| Interventions | Rifaximin |
| Enrollment | 660 |
| Start date | Dec 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Sep 1, 2008 |
| First posted | May 19, 2006 |
| Last update posted | Nov 25, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: